Diagnosis

IVF for Male Factor

Low count/motility — ICSI is the standard answer.

Low count/motility — ICSI is the standard answer. For male factor, Male factor is the classic ICSI indication — a single sperm injected per egg; success then tracks the female partner's age.

Success by egg type and age

The chart below shows live-birth rate per embryo transfer from public registries — the single most important number for male factor, because the cost per baby is the country price multiplied by the cycles you are likely to need.

Live-birth rate per embryo transfer by egg type & age
Donor (any age)%48
Own <35%48
Own 38-40%32
Own 41-42%18
Own 43+%8

Chart: live-birth % per transfer — donor-egg success stays ~48% at any age, while own-egg success falls with maternal age (SART/CDC 2019, ESHRE/EIM).

Best-fit route & where to go

Treatment route and the true cost per baby depend on your age and egg situation — model it in the cost-per-baby calculator. For male factor we most often compare Czechia, Greece, Spain, Turkey, Poland.

Send your records for a free match with clinics experienced in Male Factor.

How male factor affects IVF success

Low sperm count, motility or morphology is the classic indication for ICSI, where a single sperm is injected directly into each egg. Once fertilisation is achieved this way, live-birth odds then track the female partner's age on the same registry curve (CDC/HFEA), because the egg, not the sperm, is the main limiting factor in most cases. Severe male factor may need surgical sperm retrieval; donor sperm is the fallback where no viable sperm are found.

Male factor and ICSI

Low sperm count, motility, or morphology is treated with ICSI (intracytoplasmic sperm injection), where a single sperm is injected directly into each egg. Once fertilisation is achieved, live-birth odds track the female partner's age on the standard registry curve (CDC/HFEA), because the egg, not the sperm, is the main limiting factor in most cases. Severe male factor may need surgical sperm retrieval (TESE/MESA); donor sperm is the fallback where no viable sperm are found.

What the registries actually show

IVF success is driven mainly by maternal age and egg type, not by the country you choose. The public registries put own-egg live birth at roughly:

Sources & evidence

The success figures on this page come from national IVF registries, not clinic marketing. Primary sources:

Compiled and fact-checked by the BabyPath editorial team against the registries above. Per-retrieval (CDC) and per-transfer (HFEA) use different denominators — both are shown so the numbers are not misread. Educational information, not medical advice; outcomes vary by individual and clinic — always consult a licensed fertility specialist.

Frequently asked questions

How is IVF approached for male factor?

Male factor is the classic ICSI indication — a single sperm injected per egg; success then tracks the female partner's age.

What are the success rates with male factor?

Own-egg success tracks maternal age — roughly 48% under 35, ~32% at 38–40 and ~8% by 43 — while donor eggs hold near 48% at any age (SART/CDC and ESHRE registries).

Which countries are best for male factor?

We compare Czechia, Greece, Spain, Turkey, Poland on cost per baby, live-birth success and legal eligibility — see the by-destination links below.

Does male factor change the cost per baby?

Yes — cost per baby is the country price multiplied by the number of cycles you are likely to need, and your diagnosis shifts expected success, so the cheapest sticker price is rarely the cheapest baby.

Can I still use my own eggs with male factor?

Often yes, especially under about 38; where ovarian reserve is low, donor eggs can be the cheaper and faster route to a live birth. Model both in the calculator.

Data sources & medical review

The success rates, cost ranges and legal-eligibility rules on this page are compiled from public clinical registries and national guidelines — not opinion. They are planning estimates and do not replace advice from a licensed fertility specialist.

Reviewed against: HFEA (UK), SART/CDC (US), ESHRE/EIM (EU) and NICE CG156.

Compiled and fact-checked by the BabyPath editorial team against the primary sources above · last reviewed 2026-06-12 · BabyPath is an independent cross-border comparison platform, not a clinic. Always consult a licensed clinician before starting treatment.

Find the country where your baby costs the least.

We compare IVF success rates, prices and laws across 12 countries — using real CDC, HFEA and ESHRE data — to show your true cost per baby, not per cycle. Donor eggs, age 40+, single or same-sex: we show where it's affordable and legal for you.

Get 3 matched clinic quotes — free